3 Stocks to Buy When Your Government Shuts Down Motley Fool Biogen continues to invest in multiple sclerosis, with a late-stage study under way for daclizumab and regulatory filings already submitted for Plegridy. However, Biogen's pipeline holds promise in other areas as well. It awaits approval for drugs that ... |
